Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TLSI

+ Watchlist+ Portfolio

TriSalus Life Sciences, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.30
52-Week Range
$2.17 – $7.95
Market Cap
$151.16M
P/E (TTM)
—
EPS (TTM)
-0.41
Dividend Yield
0.00%
Advanced Metrics
Price/Book
222.73
PEG Ratio
—
Return on Equity
—
Return on Assets
-38.82%
Gross Margin
86.46%
Operating Margin
-62.96%
Profit Margin
-56.60%
Current Ratio
4.22
Debt/Equity
49.55
Total Debt
$33.69M
Free Cash Flow
$-11.61M
Revenue Growth
11.30%
Earnings Growth
—
Enterprise Value
$143.80M

Market Snapshot

About

TriSalus Life Sciences, Inc. is a medical technology company developing innovative interventional oncology devices and therapies. The company focuses on pressure-enabled drug delivery systems designed to improve outcomes for liver cancer patients.